Market size, share and growth analysis by product, application and end user, across all major regions and key countries, with forecasts for 2023–2032. The competitive landscape profiles 19+ companies, including Bionano Genomics and Illumina Inc..
The global optical genome mapping market was valued at USD 105 Mn in 2023 and is projected to reach USD 329 Mn by 2032, growing at a CAGR of 17.5%. Europe is the largest regional market and Asia-Pacific is growing fastest.
Global Optical Genome Mapping Market was valued at USD 104.9 Million in 2023 and is expected to reach USD 329.2 Million by 2032, at a CAGR of 17.5% during the forecast period 2023 - 2032.
Source: Custom Market Insights analysis.
To learn more about this report - request a sample report PDF
Optical genome mapping is a study of genomics technology that uses high-resolution images of particular DNA molecules to determine structural changes and genomic organization. Optical genome mapping gives significant insight into genomic structure and diversity, which aids in the study of hereditary illnesses, cancer genetics, biological evolution, and genome assembly.
Optical Genome Mapping Market Growth Factors
Rising awareness among the population related to prenatal testing
The growing public awareness of prenatal testing is a crucial driver for the optical genome mapping industry. As people become more aware of the significance of prenatal screening in detecting genetic abnormalities and hereditary illnesses in unborn kids, there is an increasing need for improved technologies that provide complete and precise genomic analysis.
Because of its capacity to detect major structural alterations in the human genome with high resolution and sensitivity, optical genome mapping is an effective prenatal diagnostic method. This approach outperforms established methods such as karyotyping and fluorescence in situ hybridization by offering a more complete picture of the genome.
For instance, Bionano Genomics, Inc. announced the release of the second interim report from ongoing clinical research aimed at establishing OGM as the standard of care (SOC) in the identification of genetic illness in prenatal individuals. This paper describes the prenatal genetic disorder clinical trial program, which aims to test OGM as an alternative to SOC processes.
Increasing demand for advanced genomic analysis tools and techniques
The growing need for better genomic analysis tools and methodologies is a significant driver of the optical genome mapping industry. As academics and doctors seek more extensive and reliable ways of researching genes, optical genome mapping provides significant benefits.
Its capacity to directly see large-scale genomic structural variations closes a critical gap left by standard sequencing methods, which may overlook specific types of structural variants. Furthermore, optical genome mapping allows for quick, cost-effective, and scalable genome analysis, making it appealing for a variety of applications such as clinical diagnostics, customized healthcare, and industrial genomics.
The expanding acceptance of optical genome mapping in research facilities, academic institutions, and clinical settings underlines the necessity for strong genomic analytic tools capable of offering complete insights into genome structure.
For instance, a new genomic mapping technique may provide secrets for treating blood malignancies. Scientists have grown increasingly capable of detecting SVs as the next-generation genomic analysis technology and procedures have advanced. The team next utilized statistical analysis to compare the SVs in the optical genome mapping results to the outcomes from the drug sensitivity testing.
Optical Genome Mapping Market: Restraints
High cost of instrument and services
The high expense of instruments and services creates a substantial obstacle to entry for many potential optical genome mapping industry participants. The initial cost of obtaining the specialized equipment and infrastructure necessary for optical genome mapping might be prohibitively expensive for academic institutes, clinical laboratories, and smaller biotechnology enterprises.
Additionally, the fees related to consumables, maintenance levels, and technical support add to the total cost of implementing this technology. As a result, budget restrictions may discourage businesses from selecting optical genome mapping, restricting its widespread use and market penetration.
Furthermore, the high cost of services provided by organizations that offer optical genome mapping as a service may constitute a barrier for potential clients looking for low-cost genetic analysis solutions.
Optical Genome Mapping Market: Opportunities
Innovations in high-resolution imaging and data analysis algorithms
Innovations in high-resolution imaging, DNA tagging, and data processing techniques are propelling the optical genome mapping sector. High-resolution imaging technologies, such as improved microscopy and nanoimaging methods, allow for a clear and detailed image of individual DNA molecules, making structural alterations in the genome easier to identify.
Improved DNA labelling technologies, such as fluorescent colours and sequence-specific labels, increase the intensity and specificity of DNA molecules, allowing for more exact mapping of genomic characteristics.
Furthermore, advances in data analysis technologies, like as machine learning and bioinformatics tools, allow for the effective processing and interpretation of massive volumes of genomic data generated by optical genome mapping. These advancements cumulatively lead to the widespread use of optical genome mapping in a variety of domains, including clinical diagnostics, customized healthcare, and fundamental research.
For instance, according to Oxford research, DeepOM is a novel computer approach for optical genome mapping that makes use of deep learning. The use of convolutional neural networks that are trained on simulated pictures of tagged DNA molecules increases the success rate in aligning DNA images to genetic references.
OGM uses include pathogen detection in clinical samples and genome-wide mapping of impacts such as DNA damage and structural variation.
Optical Genome Mapping Market: Segmentation Analysis
The Global Optical Genome Mapping market is segmented by product, application, end user and region. Based on product, the market is classified into consumables, services & software and instruments. Services and software dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
Services and software are major drivers of the optical genome mapping business, improving the accessibility, efficiency, and understanding of genomic data produced by this technique. Sample preparation, data capture, and data analysis are examples of service solutions that give researchers simplified workflows and professional support, lowering the barrier to the adoption of optical genome mapping.
Furthermore, software technologies facilitate efficient data administration, visualization, and analysis allowing researchers to derive valuable insights from complicated genomic datasets. These software systems frequently include advanced algorithms for structural variant discovery, annotation, and comparative genomics, allowing researchers to find clinically relevant genomic changes and explain their functional consequences.
Furthermore, service providers and software developers are constantly innovating to improve the scalability, accuracy, and usability of optical genome mapping technology, boosting market expansion.
Based on application, the market is classified into genome assembly, structural variation detection, microbial strain typing, haplotype phasing and others. The structural variation detection segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
The discovery of structural variants (SVs) is a key driver of the optical genome mapping (OGM) sector. SVs, which comprise large-scale genomic rearrangements like as deletions, duplications, inversions, and translocations, are critical for understanding genetic disorders, cancer biology, and population variation. Optical genome mapping is a complementary method that involves photographing and examining individual DNA molecules at high resolution.
This method allows for thorough identification of SVs across the genome, including repetitive sections and complicated rearrangements, with fewer false positives and negatives. OGM has gained popularity in studies, medical diagnostics, and pharmaceutical industries, fuelling market expansion by meeting the unmet demand for robust and accurate SV detection in genomics.
Based on end users, the market is classified as biotechnology & pharmaceutical companies, academic & research institutions, and others. The biotechnology & pharmaceutical companies segment dominated the market in 2022 with a market share of 55% and is expected to keep its dominance during the forecast period 2024-2032.
Biotechnology and pharmaceutical firms are crucial in moving the optical genome mapping market ahead through a variety of channels. These businesses frequently have significant R&D resources committed to improving genomic technology.
Furthermore, biotech and pharmaceutical companies use optical genome mapping for a variety of purposes, including drug development, precision medicine, and biomarker identification.
Moreover, organizations frequently partner with technology vendors to develop solutions customized to their unique research or clinical needs, hence promoting further innovation and adoption of optical genome mapping technologies in both fundamental research.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 104.9 Million |
| Projected Market Size in 2032 | USD 329.2 Million |
| Market Size in 2022 | USD 94.5 Million |
| CAGR Growth Rate | 17.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Optical Genome Mapping Market: Regional Analysis
By region, Optical Genome Mapping market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Optical Genome Mapping market in 2022 with a market share of 40% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.
North America drives the optical genome mapping industry through a variety of factors. To begin, the area is home to several renowned biotechnology and genomics businesses that research and commercialize cutting-edge technologies.
North America is home to world-renowned research organizations and colleges that are performing ground-breaking genomics and genetics research. Their desire for improved genetic analysis tools drives market expansion and acceptance.
Furthermore, coordinated cooperation across academia, business, and government programs encourages technological development and adoption. Furthermore, North America's favourable regulatory framework and extensive healthcare infrastructure make optical genome mapping more easily integrated into clinical applications like diagnostics and customized therapy.
Overall, the North American ecosystem of research, innovation, and industry leadership work together to fuel the expansion of the optical genome mapping market in the region and globally.
Optical Genome Mapping Market: Recent Developments
List of the prominent players in the Optical Genome Mapping Market:
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Optical Genome Mapping Market is segmented as follows:
By Product
By Application
By End User
Regional Coverage:
North America
Europe
Asia Pacific
The Middle East & Africa
Latin America
Updated: January 2026 · Formats: PDF, Excel, PPT
The restraints of the Optical Genome Mapping market is high cost of instrument and services.
The major driver for the Optical Genome Mapping market is rising awareness among the population related to prenatal testing and increasing demand for advanced genomic analysis tools and techniques.
The "Consumables" category dominated the market in 2022.
The key players in the market are Bionano Genomics, Illumina Inc., Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Zymo Research Corp., Bio-Rad Laboratories Inc., PerkinElmer Inc., Roche Diagnostics, 10X Genomics, Bionano Genomics, NanoString Technologies Inc., GenapSys Inc., Cytoscan Technologies Inc., Danaher Corporation, Qiagen N.V., BGI Genomics Co. Ltd., Caris Life Sciences, Exact Sciences Corporation, Others.
"North America" had the largest share in the Optical Genome Mapping Market.
The global market is projected to grow at a CAGR of 17.5% during the forecast period, 2023-2032.
The Optical Genome Mapping Market size was valued at USD 104.9 Million in 2023.
Author · Sr. Research Analyst
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
Buy individual chapters for $490 each: 8 chapters available, from Executive Summary to Company Profiles.
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sample